Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2010
06/03/2010US20100136595 Hydrocarbon-forming oxidative decarbonylase enzyme, hydrocarbons produced thereby, and method of use
06/03/2010US20100136590 Method of Determining NT-proBNP
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136169 Novel asparaginases and uses thereof
06/03/2010US20100136113 Phytases, nucleic acids encoding them and methods for making and using them
06/03/2010US20100136058 DNA vaccines against tumor growth and methods of use thereof
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136028 Antagonists of pcsk9
06/03/2010US20100136018 Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
06/03/2010US20100136015 Methods and compositions for regulating iron homeostasis by modulation of bmp-6
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100136007 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010US20100136005 Method of Treatment Using Humanized Anti-CD11a Antibodies
06/03/2010US20100135959 Human Interferon Molecules and Their Uses
06/03/2010US20100135957 Chimeric Heteromultimer Adhesins
06/03/2010CA2746984A1 Method for preparing of human recombinant insulin
06/02/2010EP2192185A1 Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same
06/02/2010EP2192184A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin
06/02/2010EP2192131A1 Immunoglobulins devoid of light chains
06/02/2010EP2192130A1 Human DR4 antibodies and uses thereof
06/02/2010EP2191845A1 Immunology significant herpes simplex virus antigens and methods for using same
06/02/2010EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
06/02/2010EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9
06/02/2010EP2190856A2 Polypeptides with modified amino acids
06/02/2010EP1697534B1 Nucleic acid molecules containing recombination sites and methods of using the same
06/02/2010EP1534736B1 Nogo receptor antagonists
06/02/2010CN1966709B Process for preparing recombinant Sinkiang domestic silkworm antibiotic peptide, Sinkiang domestic silkworm antibiotic peptide therefrom, and use thereof
06/02/2010CN1800385B Hybrid expression of neisserial proteins
06/02/2010CN1659180B Novel recombinant anticoagulant proteins
06/02/2010CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon
06/02/2010CN1291231B Human telomerase catalytic subunit
06/02/2010CN101717808A Method for preparing rice protein with high dissolubility
06/02/2010CN101717807A Process for preparing chicken liver hydrolyzed protein with proteases
06/02/2010CN101717806A Integrated peptidoglycan and preparation method thereof
06/02/2010CN101717805A Method for preparing wheat protein source opioid peptide by enzymolysis of wheat protein
06/02/2010CN101717804A Method for preparing medical III type collagen
06/02/2010CN101717763A Method for improving stability of liquid aminopeptidase and application of aminopeptidase
06/02/2010CN101717744A Gene recombination bacillus amyloliquefaciens and microbial inoculum preparation method
06/02/2010CN101717737A Antibiotic peptide buforin II and porcine INF-alpha fusion expression pichia pastoris, and preparation method and applications thereof
06/02/2010CN101717442A Polyethylene glycol recombination DesB30 human insulin, preparation method and application thereof
06/02/2010CN101716334A Biological medicament for treating ischemic cardiovascular disease and skin ulcer
06/01/2010US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection
06/01/2010US7728115 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis
06/01/2010US7728114 Cluster of differentiation (CD3) specific monoclonal antibody for use in treatment and prevention of autoimmune and transplant disorders
06/01/2010US7728113 Methods of treating arthritic conditions with antibodies to M-CSF
06/01/2010US7728111 Anti-p55 TNF receptor antibody
06/01/2010US7728110 Immunoglobulin specific to severe acute respiratory syndrome (SARS) corona virus for use in diagnosis, prevention and treatment of viral diseases associated with respiratory system
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7727748 Method for producing D-pantothenic acid and/or salts thereof via purification by anion exchange as an additive for animal feed
06/01/2010US7727744 Using transposon insertion to genetically engineer proteins, identify protein domains, change protein functionality, epitope map and prepare antigenic peptides for production of vaccines
06/01/2010US7727743 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
06/01/2010US7727742 Nucleic acid molecules encoding fibroblast growth factor-like polypeptides
06/01/2010US7727741 Nucleotide sequences coding glycoengineered peptides with enhance Fc receptor binding affinity and effector function for treatment and prevention of cell proliferative disorders
06/01/2010US7727738 Methods for generating analogs of coenzyme A
06/01/2010US7727736 Monitoring Factor Xa or thrombin enzyme activities using enhanced phosphatidylserine (PS), phosphatidylhomoserine, phosphatidylethanolamine and/or phosphatidic acid; improved shelf-life, reproducibility and ease of manufacture
06/01/2010US7727729 Using taste specific g protein coupled receptors as tools in identifying modulator which can be used to customize taste in food and pharmaceuticals
06/01/2010US7727572 food products such as doughs and dairy products, animal feed, pharmaceuticals, cosmetics, dental care products
06/01/2010US7727529 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
06/01/2010CA2512040C Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
06/01/2010CA2442679C Methods for secretory production of proteins
06/01/2010CA2441952C Plasmodium falciparum ama-1 protein and uses thereof
06/01/2010CA2304376C Dna-construct for the tissue-specific expression of a blood coagulation factor
06/01/2010CA2288600C A method for making multispecific antibodies having heteromultimeric and common components
06/01/2010CA2288373C Human cerberus protein
06/01/2010CA2212577C Bacillus proteases
05/2010
05/27/2010WO2010059626A1 Filamentous fungi with impaired ptrb activity for altered protein production
05/27/2010WO2010059543A1 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
05/27/2010WO2010058427A2 Process for production and purification of polymyxin b sulfate
05/27/2010WO2010057961A1 Peptide synthesis using enzymatic activation and coupling
05/27/2010WO2010038145A3 Kit for the optimisation of protein synthesis/secretion
05/27/2010WO2010033753A3 Mutant delta5 desaturases and their use in making polyunsaturated fatty acids
05/27/2010WO2010027516A3 Transgenically preventing establishment and spread of transgenic algae in natural ecosystems
05/27/2010WO2010013934A3 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same
05/27/2010WO2010002862A3 Fibroblast growth factor receptor 3 (fgfr3) binding proteins
05/27/2010WO2009049274A8 Microorganism engineered to produce isopropanol
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130720 Artificial binding proteins based on a modified alpha helical region of ubiquitin
05/27/2010US20100130590 Deletion bearing bard1 isoforms and use thereof
05/27/2010US20100130433 Casein-Derived Peptides having Anxiolytic Activity
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100129869 Methods and compositions for inactivating glutamine synthetase gene expression
05/27/2010US20100129868 Delta 4,5 glycuronidase compositions and methods related thereto
05/27/2010US20100129867 Method for producing dipeptide
05/27/2010US20100129866 Method for production of dipeptide
05/27/2010US20100129865 Ketose 3-epimerase, its preparation and uses
05/27/2010US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
05/27/2010US20100129863 Optimized core promoters and uses thereof
05/27/2010US20100129862 Novel lipolytic Enzyme lip1
05/27/2010US20100129861 Isolation and Use of Novel Mammalian DExH Box Helicases
05/27/2010US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support